TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: C-statistics for predictive ability of the nomogram
Endpoint domain: Mortality/survival
Primary endpoint: Subjective symptoms of ocular irritation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ratio of muscle thickness to contraction and relaxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased activity of the deep trunk muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall quality of the evaluation experience
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: performance of basic microsurgical tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of early postoperative otorrhoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of ventilation tube obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in social-cognitive skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in social behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in interpersonal relationships
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: 30-s chair sit to stand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-s arm curl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 8-ft up-and-go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life in individuals with low vision
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: death, stroke or transient ischaemic attack, or major bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Cz theta values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cz alpha values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COP-v (center of pressure velocity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: readiness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: expected performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Accuracy of right serve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of left serve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of crosscourt backhand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of forehand shot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: StimQ total score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Parent‐Child Interaction Rating Scales - Infant Adaptation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Language quantity and quality
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvement in microsurgical skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wisconsin scale total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Leucocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: postsurgical opioid consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pruritus severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symbol Digit Modalities Test (SDMT) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: β‐endorphin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transthyretin levels in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge about small mass risks and treatments
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of patients discussing ablation
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Reduction in N-terminal pro–B-type natriuretic peptide concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite of cardiovascular death or HF rehospitalization
Endpoint domain: Mortality/survival
Primary endpoint: KOOS subscores (Function and knee-related quality of life)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proficiency Score (PS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temporal demand scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Sino‐Nasal Outcome Test‐22 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients using NSAIDs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: SAS score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lowering childbirth fear
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mid-facial soft tissue changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: labial bone thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytokine levels in tears and conjunctiva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: knee angle during midstance while wearing footwear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum knee angle during swing while barefoot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants completing the intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants remaining blinded to group allocation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of intervention-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: recall accuracy of vaccination reasons
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: autonomous motivation scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinically significant PSAS
Endpoint domain: Adverse events/effects
Primary endpoint: Average segment length of NREM sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Segment length of wake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of SOL misperception
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: improved muscle function (peak torque, relative peak torque, total work)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: increase in erythrocyte deformability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: NRS pain score at rest 24 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS pain score during quick movement/coughing 24 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Substandard quality of timolol maleate eye drops
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of miR‐23a‐3p and miR‐206
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intention to have the test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FMA-UE proximal score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FMA-UE total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reaction time of the two-back task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: count of commission errors in the alertness task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Gait speed, frequency and length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum inflammatory factors (TNF‐α and IL‐1β)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MetS reversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight-for-age gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence rate of neuralgia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prophylaxis of vomiting in the first 48 h after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median time to explantation
Endpoint domain: Mortality/survival
Primary endpoint: probabilities of implant survival
Endpoint domain: Mortality/survival
Primary endpoint: explantation rate
Endpoint domain: Mortality/survival
Primary endpoint: Total urticaria severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 25‐hydroxyvitamin D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum concentrations of IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: serum concentrations of tumor necrosis factor-α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: serum concentrations of IL-10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: serum concentrations of malondialdehyde
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in patient stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Occurrence of early epileptic seizures
Endpoint domain: Adverse events/effects
Primary endpoint: Optic nerve head blood volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Optic nerve head oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: total mental test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of people without a cognitive disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-rater agreement (κ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGI-S and GAF scores
Endpoint domain: Life impact
Endpoint subdomain: Functional impairment
Primary endpoint: Quick-DASH scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time until stopping analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pressure-related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRNA expression level of KCNQ1OT1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: miR‐146a‐3p expression level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cell proliferation, invasion and migration capacities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to hospital discharge or ready for discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete improvement of plane warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: recurrence of plane warts
Endpoint domain: Adverse events/effects
Primary endpoint: Correct positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of attempts to access lumbar puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of HRDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: return to operating room
Endpoint domain: Adverse events/effects
Primary endpoint: readmission
Endpoint domain: Adverse events/effects
Primary endpoint: MoCA total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: ADAS‐Cog domain score of attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: serum Hcy levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in ESAS symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Approximal marginal bone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial dinner glucose concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: impaired running time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: jump height reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall QoL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hospital Length of Stay (LoS)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Proportion of abdominal pain responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall quality of life (QOL) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of BP dipper profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean BP dip
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of pericatheter leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of catheter displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in interleukin‐6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: preservation of the periarticular soft tissue envelope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of component positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average long-term bowel quality of life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Work attendance rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Time to reach target blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of inflammatory markers (TNF‐α, IL‐1, IL‐6, IL‐10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in median blood pressures and heart rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease of inflammatory markers (IL-1 beta, IL-6, TNF-alpha)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: frequency of migraine headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posttreatment bacterial density log10 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Posttreatment adenosine triphosphate log10 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rectus femoris muscle area change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: time to recovery of ADLs
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Adjusted mean change in BCVA score from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients not receiving supplemental ranibizumab treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Ocular adverse events of special interest
Endpoint domain: Adverse events/effects
Primary endpoint: Change in mucosa color
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhaled salbutamol lung dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Precipitation in the oral cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thyroglobulin (Tg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Free Thyroxine (FT4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: motion smoothness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incident AF
Endpoint domain: Mortality/survival
Primary endpoint: any hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient satisfaction with VR intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health state utility values (HSUVs)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Retention of full health at Week 23 and Week 52
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Deterioration in EQ‐5D‐Y
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean scores for vasomotor symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Opioid tablet usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pain Intensity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-effectiveness of augmented CBT for moderate/severe depression
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: BFlh %MVIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ST %MVIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: lnRMSSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: lnSDNN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occupational burnout
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oxytocin-to-delivery interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: MACE outcome
Endpoint domain: Mortality/survival
Primary endpoint: ASCVD risk score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean decline in GFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Accuracy in assessing number of casualties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to assess number of casualties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ranking of anesthesiologists' confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ranking of anesthesiologists' intelligence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Likelihood of choosing anesthesiologist to care for family member
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: socket wound closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in foot pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in foot function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: composite cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: compensated portion of the ramp test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of salivary S. mutans colonies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Effectiveness of CPAP vs nHF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost comparison of CPAP vs nHF
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: knowledge of mental health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in mMASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients making errors related to handling the device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical status at 15 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular protection during COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Venous thromboembolism (VTE) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Overall risk stratification rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of referrals of high-risk patients to psychologically informed physical therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: feeling of disconnection from the work environment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing